Our mathematical model was validated against the previously observed and simulated effects of the regulation of EGF, PP2A, MKP3 on ERK activities and the regulation of EGF on RasGTP, and its predicted anti-proliferate effects of EGFR, BRaf and MEK inhibitors were compared to the experimental cancer cell-line growth inhibition GI50 values. Here, EGF is linked to cancer.